Clinical significance of completion of radium-223 treatment and acute adverse events in patients with metastatic castration-resistant prostate cancer.
Takeda K, Kawasaki Y, Sakayauchi T, Takahashi C, Katagiri Y, Tanabe T, Ishikawa Y, Fujimoto K, Kubozono M, Kozumi M, Abe K, Narazaki K, Tasaka S, Umezawa R, Yamamoto T, Takahashi N, Suzuki Y, Kishida K, Omata S, Ito A, Jingu K.
Takeda K, et al. Among authors: fujimoto k.
Asia Ocean J Nucl Med Biol. 2023;11(1):13-22. doi: 10.22038/AOJNMB.2022.67136.1468.
Asia Ocean J Nucl Med Biol. 2023.
PMID: 36619192
Free PMC article.